Filing Details

Accession Number:
0001209191-15-054333
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-17 18:04:08
Reporting Period:
2015-06-15
Filing Date:
2015-06-17
Accepted Time:
2015-06-17 18:04:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1066040 Jr E Francis Odonnell C/O Biodelivery Sciences Intl, Inc.,
4131 Parklake Avenue, Suite 225
Raleigh NC 27612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 4,105 $0.00 172,825 No 4 A Direct
Common Stock Disposition 2015-06-16 1,597 $7.97 171,228 No 4 S Direct
Common Stock Disposition 2015-06-16 20,000 $8.03 151,228 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of restricted stock units granted under the Registrant's Performance Long Term Incentive Plan.
  2. The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
  3. On June 16, 2015, the Reporting Person sold an aggregate of 1,597 shares of the Issuer's Common Stock at a weighted average price of $7.97. The highest sale price for the Common Stock was $8.07 per share and the lowest sale price was $7.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The shares of common stock were sold under a pre-planned 10b5-1 trading plan.
  5. On June 16, 2015, the Reporting Person sold an aggregate of 20,000 shares of the Issuer's Common Stock at a weighted average price of $8.03. The highest sale price for the Common Stock was $8.19 per share and the lowest sale price was $7.87 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.